Position in AXGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,005,490
+$1,135,633 QoQ
Shares Held
65,068
+15.3% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. AXGN ranks #27 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in AXGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,005,490 | 65,068 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,869,857 | 56,440 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,822,962 | 55,697 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,157,584 | 64,887 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $703,655 | 64,853 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,114,884 | 60,264 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $959,663 | 58,232 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $795,088 | 56,711 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $421,056 | 58,157 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $442,050 | 54,777 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $362,857 | 53,127 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $273,530 | 54,706 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $496,480 | 54,379 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $499,451 | 52,852 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $534,069 | 53,514 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $623,416 | 52,300 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $397,698 | 48,559 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $327,715 | 41,274 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $382,867 | 40,861 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $668,766 | 42,327 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $877,668 | 40,614 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $880,560 | 43,463 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $822,916 | 45,973 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $508,498 | 43,723 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $461,796 | 49,978 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $479,700 | 46,125 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||